Genetics and Genomics

Size: px
Start display at page:

Download "Genetics and Genomics"

Transcription

1 Genetics and Genomics Presented by Maxine Chang, ARNP, AGN, OCN 2/16/2018 1

2 What Is Genetic Counseling? The process of helping people understand and adapt to the medical, psychological and familial implications of genetic contributions to disease (NSGC) NOT JUST GENETIC TESTING!!!

3 Other counselors Counseling offered by trained professionals other than Genetic Counselors. Advanced Practice Nurses certified in Genetics may offer counseling Registered Nurses with certification in Genetics ARNP and Nurses are NOT considered to be Genetic Counselors. Counseling may be for cancer, diabetes, Alzheimer s disease, cardiac diseases, rare congenital diseases and reproductive issues.

4 Genetic Testing Options Single gene/syndrome testing (e.g., BRCA1 & BRCA2) Multi-gene panel testing High-risk genes (e.g., BRCA1, BRCA2, TP53, PALB2) Moderate-risk genes (e.g., ATM, CHEK2) Cost of testing is generally not a barrier to access

5 Who should be referred? Diagnosed at a younger-than-typical age e.g., breast or colon under 50 Multiple primary cancers Remote history of previous cancer(s) or synchronous cancers Rare types of cancer e.g., ovarian, TNBC, male breast, pheo/paragangliomas, MTC, metastatic prostate cancer Family history of cancer Each side of the family is separate Update testing Previous BRCA without BART or previous testing without a panel Germline implications from somatic (tumor) testing

6 Who should be referred? Diagnosed at a younger-than-typical age e.g., breast or colon under 50 Multiple primary cancers Remote history of previous cancer(s) or synchronous cancers Rare types of cancer e.g., ovarian, TNBC, male breast, pheo/paragangliomas, MTC, metastatic prostate cancer Family history of cancer Each side of the family is separate Update testing Previous BRCA without BART or previous testing without a panel Germline implications from somatic testing

7

8 How do I know who to refer? Young, rare, or not the first in the family? NCCN guidelines Professional practice guidelines ASCO (multiple guidelines/recommendations) ACMG (Hampel, et al. Genet Med Jan;17(1):70-87.doi: /gim ) Patient request Ask a Genetic Counselor (x3555 or genetics@moffitt.org)

9 Case Presentation #1 Lung Ca dx 52 Breast cancer dx 85 Colon cancer dx 58 L breast cancer dx 32, R breast cancer dx 34 TP53 Variant c.542g>a (p.arg181his)

10 Case Presentation #1 (3 years later) Lung Ca dx 52 Breast cancer dx 85 TP53 Variant c.542g>a (p.arg181his) Breast cancer dx 62 TP53 Variant c.542g>a (p.arg181his) Colon cancer dx 58 L breast cancer dx 32, R breast cancer dx 34 TP53 Variant c.542g>a (p.arg181his)

11 Clinical Team Members Dr. Xia Wang Clinical Geneticists (1) Jennifer Brzosowicz Nurse Practitioner (1) Certified Genetic Counselors (5) Maxine Chang, ARNP Alma Tiscareno Genetic Counseling Assistants (2) Carolyn Haskins Laura Barton Department Coordinator (1) Kathleen Ray Christine Bruha Katelynn Simon Jessica Metzger GeneHome Clinic Dr Xia Wang and Maxine Chang, ARNP

12 GeneHome Staff Physician oversight provided by Xia Wang, M.D., Ph.D. Services performed by Maxine Chang, ARNP. 12

13 So much to learn!!!

14 Genes and chromosomes

15 DNA and RNA

16 What are SNPs? SNPs are single nucleotide polymorphisms, substitutions of one base for another that occur in more than 1% or greater in the general population. Difficult to identify SNPs that correlate with a particular effect in patients. Using SNP profiling, it may possible to tailor drug prescription and drug dosage to the individual, thereby maximizing efficacy and minimizing toxicity

17 SNPs continued This pharmacogenetic approach could save time, money, and discomfort for millions of patients through accurate diagnoses and matching patients with appropriate medicines.

18 This is a SNP

19 Genomics vs Genetics The World Health Organization defines Genomics as: the study of genes and their functions, and related techniques. The main difference between genomics and genetics is that genetics scrutinizes the functioning and composition of the single gene where as genomics addresses all genes and their inter relationships in order to identify their combined influence on the growth and development of the organism.

20 Human Genome Project The NIH describes the Human Genome Project (HGP) as an international research effort to determine the sequence of the human genome and identify the genes that it contains. Coordinated by the NIH and the U.S. Department of Energy and formally began in 1990 and completed in It was scheduled to be completed in 2005 according to NIH. Additional contributors:- Universities across the United States, United Kingdom, France, Germany, Japan, and China. The HGP has revealed that there are probably about 20,500 human genes. All our genes together are known as our genome.

21 How have things changed? The work of the Human Genome Project has allowed researchers to begin to understand the blueprint for building a person. As researchers learn more about the functions of genes and proteins, this knowledge will have a major impact in the fields of medicine, biotechnology, and the life sciences.

22 Genomic Medicine The National Human Genome Research Institute (NHGRI) defines genomic medicine as: an emerging medical discipline that involves using genomic information about an individual as part of their clinical care (eg., for diagnostic or therapeutic decision-making) and the health outcomes and policy implications of that clinical use. Oncology incorporates genomics as diagnostics for genetic and genomic markers are increasingly included in cancer screening, and to guide tailored treatment strategies.

23 Pharmacogenetics Study of the genetic basis for variability of drug response Genetic influences on an individuals reaction/response to drugs or class of drugs Br J Clin Pharmacol Oct; 52(4): doi: /j x

24 Pharmacogenomics Genetic considerations have been instrumental in explaining several pharmacologic problems. It is a tool to assist in selecting drugs (targeted therapy), dosing of drugs (avoiding toxicity) Combines traditional pharmaceutical sciences with an understanding of common DNA variations in the human genome. The most common variations are known as single nucleotide polymorphisms (SNPs). Individual variations affect the drug action.

25 Difference Between Pharmacogenetics and Pharmacogenomics? Pharmacogenetics starts with an unexpected drug response and evaluates its genetic cause, while pharmacogenomics begins with looking for genetic variations within a population that may explain certain observed responses to a therapeutic drug. Patil J (2015) Pharmacogenetics and Pharmacogenomics: A Brief Introduction. J Pharmacovigilance 3: e139. doi: / e139

26

27 Safer Drugs through Pharmacogenomics Genes change the way medication works Medications may be processed too quickly- therefore not as effective. Medications may be processed too slowly and cause harmful effects. Cancer treatments- Pain medications- Transplants (use of immunosuppressants)

28 Consider Cancer Treatment Nature 429, (27 May 2004) doi: /nature02626

29 Pain Medications

30 Personalized Medicine at Moffitt

31 Case Presentation #2 Breast cancer dx 40 Neurofibromas (multiple) CAL spots Prostate cancer dx 54 Neurofibromas (multiple) CAL spots 32 yo >50 cutaneous neurofibromas, > 6 CAL spots Bilateral axillary freckling Large plexiform neurofibroma on right hip Pain level 10/10 Specimen of neurofibroma submitted for FoundationOne testing

32

33 Case Presentation #2 Breast cancer dx 40 Neurofibromas (multiple) CAL spots Prostate cancer dx 54 Neurofibromas (multiple) CAL spots 32 yo >50 cutaneous neurofibromas, > 6 CAL spots Bilateral axillary freckling Large plexiform neurofibroma on right hip Pain level 5/10 FoundationOne NF1 F1708fs*, splice site 731-1G>A Started trametinib x 4 months

34 OncotypeDX test report

35

36 What s New??

37 Role of Nurses Genetics Education Patient advocacy Participating in research

38 Available training and certification Genetics program for Nurses at Cincinnati Children's Hospital. Genetics/Genomics Competency Center funded by National Institutes of Health s National Human Genome Research Institute (NHGRI). Global Genetics and Genomics Community (web based). International Society of Nurses in Genetics (ISONG). (Oncol Nurs Forum Mar;42(2): doi: /15.ONF ) Oncology Nursing Society

39 Take Away Genetics and Genomics are changing the face of medicine. We should not be left behind! There is so much more coming- STAY TUNED.

40

Assessing the Status of BRCA Testing and the Challenges Faced by Cancer Care Teams in the Community

Assessing the Status of BRCA Testing and the Challenges Faced by Cancer Care Teams in the Community Assessing the Status of BRCA Testing and the Challenges Faced by Cancer Care Teams in the Community Summary of Survey Findings April 2018 In March 2018, the Association of Community Cancer Centers (ACCC)

More information

Assessing the Status of BRCA Testing and the Challenges Faced by Cancer Care Teams in the Community. Summary of Survey Findings April 2018

Assessing the Status of BRCA Testing and the Challenges Faced by Cancer Care Teams in the Community. Summary of Survey Findings April 2018 Assessing the Status of BRCA Testing and the Challenges Faced by Cancer Care Teams in the Community Summary of Survey Findings April 2018 In March 2018, the Association of Community Cancer Centers (ACCC)

More information

Hereditary Breast and Ovarian Cancer Rebecca Sutphen, MD, FACMG

Hereditary Breast and Ovarian Cancer Rebecca Sutphen, MD, FACMG Hereditary Breast and Ovarian Cancer 2015 Rebecca Sutphen, MD, FACMG Among a consecutive series of 11,159 women requesting BRCA testing over one year, 3874 responded to a mailed survey. Most respondents

More information

A guide to genetic testing for hereditary cancers

A guide to genetic testing for hereditary cancers Cancer Testing Solutions A guide to genetic testing for hereditary cancers The benefit of knowing TM Hereditary cancer genetic testing can play a critical role in managing health Cancer touches millions

More information

Genetic Testing: who, what, why?

Genetic Testing: who, what, why? Genetic Testing: who, what, why? Gina Westhoff MD LMG Gynecologic Oncology March 16, 2019 Disclosures Speaker for Merck (unrelated to today s topic) Objectives Determine who should undergo genetic risk

More information

Hereditary Prostate Cancer: From Gene Discovery to Clinical Implementation

Hereditary Prostate Cancer: From Gene Discovery to Clinical Implementation Hereditary Prostate Cancer: From Gene Discovery to Clinical Implementation Kathleen A. Cooney, MD MACP Duke University School of Medicine Duke Cancer Institute (No disclosures to report) Overview Prostate

More information

WHAT IS A GENE? CHROMOSOME DNA PROTEIN. A gene is made up of DNA. It carries instructions to make proteins.

WHAT IS A GENE? CHROMOSOME DNA PROTEIN. A gene is made up of DNA. It carries instructions to make proteins. WHAT IS A GENE? CHROMOSOME GENE DNA A gene is made up of DNA. It carries instructions to make proteins. The proteins have specific jobs that help your body work normally. PROTEIN 1 WHAT HAPPENS WHEN THERE

More information

Updates in Cancer Genetics & Genomics

Updates in Cancer Genetics & Genomics Updates in Cancer Genetics & Genomics Jennifer R. Klemp, PhD, MPH, MA Associate Professor of Medicine, Division of Clinical Oncology Director, Cancer Survivorship Co-Program Leader, Cancer Prevention and

More information

Why Test for Hereditary Cancer in Preventive Care?

Why Test for Hereditary Cancer in Preventive Care? Why Test for Hereditary Cancer in Preventive Care? Millions of people are sidelined by cancer. Wouldn't it be worth it for your patients to know their risk? background HEREDITARY (5-10%) More than 1 in

More information

WHAT IS A GENE? CHROMOSOME DNA PROTEIN. A gene is made up of DNA. It carries instructions to make proteins.

WHAT IS A GENE? CHROMOSOME DNA PROTEIN. A gene is made up of DNA. It carries instructions to make proteins. WHAT IS A GENE? CHROMOSOME E GEN DNA A gene is made up of DNA. It carries instructions to make proteins. The proteins have specific jobs that help your body work normally. PROTEIN 1 WHAT HAPPENS WHEN THERE

More information

The Next Generation of Hereditary Cancer Testing

The Next Generation of Hereditary Cancer Testing The Next Generation of Hereditary Cancer Testing Why Genetic Testing? Cancers can appear to run in families. Often this is due to shared environmental or lifestyle patterns, such as tobacco use. However,

More information

Multigene Panel Testing for Hereditary Cancer Risk

Multigene Panel Testing for Hereditary Cancer Risk Multigene Panel Testing for Hereditary Cancer Risk Dana Zakalik, M.D. Director, Nancy and James Grosfeld Cancer Genetics Center Professor, OUWB Medical School MCC Annual Meeting November 4, 2015 Outline

More information

GENETIC TESTING AND COUNSELING FOR HERITABLE DISORDERS

GENETIC TESTING AND COUNSELING FOR HERITABLE DISORDERS Status Active Medical and Behavioral Health Policy Section: Laboratory Policy Number: VI-09 Effective Date: 03/17/2014 Blue Cross and Blue Shield of Minnesota medical policies do not imply that members

More information

PRECISION INSIGHTS. GPS Cancer. Molecular Insights You Can Rely On. Tumor-normal sequencing of DNA + RNA expression.

PRECISION INSIGHTS. GPS Cancer. Molecular Insights You Can Rely On. Tumor-normal sequencing of DNA + RNA expression. PRECISION INSIGHTS GPS Cancer Molecular Insights You Can Rely On Tumor-normal sequencing of DNA + RNA expression www.nanthealth.com Cancer Care is Evolving Oncologists use all the information available

More information

Forward Looking Statements

Forward Looking Statements Forward Looking Statements Some of the information presented here today may contain projections or other forward-looking statements regarding future events or the future financial performance 15M Patient

More information

Germline Testing for Hereditary Cancer with Multigene Panel

Germline Testing for Hereditary Cancer with Multigene Panel Germline Testing for Hereditary Cancer with Multigene Panel Po-Han Lin, MD Department of Medical Genetics National Taiwan University Hospital 2017-04-20 Disclosure No relevant financial relationships with

More information

Germline Multigene Panel Testing in Oncology: Genetic Counseling Perspective

Germline Multigene Panel Testing in Oncology: Genetic Counseling Perspective Germline Multigene Panel Testing in Oncology: Genetic Counseling Perspective Sarah L. Campian, MS CGC Certified Genetic Counselor Nancy & James Grosfeld Cancer Genetics Center Objectives Identify patients/families

More information

BRCAplus. genetic testing for hereditary breast cancer

BRCAplus. genetic testing for hereditary breast cancer BRCAplus genetic testing for hereditary breast cancer Developed in collaboration with Fox Chase Cancer Center and the Arcadia University Genetic Counseling Program. Causes of Hereditary Breast Cancer familial

More information

The Role of genetic Testing for Inherited Prostate Cancer Risk

The Role of genetic Testing for Inherited Prostate Cancer Risk FOIU July 2018 The Role of genetic Testing for Inherited Prostate Cancer Risk Leonard G. Gomella, MD Chairman, Department of Urology Sidney Kimmel Cancer Center Thomas Jefferson University Philadelphia,

More information

Medical Policy Manual. Topic: Genetic Testing for Hereditary Breast and/or Ovarian Cancer. Date of Origin: January 27, 2011

Medical Policy Manual. Topic: Genetic Testing for Hereditary Breast and/or Ovarian Cancer. Date of Origin: January 27, 2011 Medical Policy Manual Topic: Genetic Testing for Hereditary Breast and/or Ovarian Cancer Date of Origin: January 27, 2011 Section: Genetic Testing Last Reviewed Date: July 2014 Policy No: 02 Effective

More information

ATHENA WISDOM INITIATIVE: RISK-BASED SCREENING FOR BREAST CANCER

ATHENA WISDOM INITIATIVE: RISK-BASED SCREENING FOR BREAST CANCER ATHENA WISDOM INITIATIVE: RISK-BASED SCREENING FOR BREAST CANCER The Screening Debate in the US? ACS vs. USPSTF When to start, when to stop, screening intervals, modality] Little guidance around operationalizing

More information

Family Assessment. Objectives. Comprehensive Family History Important Inexpensive Underutilized genetic tool

Family Assessment. Objectives. Comprehensive Family History Important Inexpensive Underutilized genetic tool Besides the BRCA genes, what else to consider in hereditary breast and ovarian cancer? Laurie M. Connors DNP, APNG, FNP-BC, AGN-BC Objectives Evaluate personal & family history to assess risk for hereditary

More information

Genetic Testing For Ovarian Cancer: When, How And Who? Judith Balmaña, MD, PhD University Hospital Vall d Hebron Barcelona, Spain

Genetic Testing For Ovarian Cancer: When, How And Who? Judith Balmaña, MD, PhD University Hospital Vall d Hebron Barcelona, Spain Genetic Testing For Ovarian Cancer: When, How And Who? Judith Balmaña, MD, PhD University Hospital Vall d Hebron Barcelona, Spain Why Would We Consider Genetic Testing in Patients With Ovarian Cancer?

More information

Assessing Your Patient s Breast Cancer Risk: Is Genetic Testing Necessary?

Assessing Your Patient s Breast Cancer Risk: Is Genetic Testing Necessary? May 16, 2016 Assessing Your Patient s Breast Cancer Risk: Is Genetic Testing Necessary? Presenter: Emily Kuchinsky, MS, CGC 1 Experiences with Genetic Testing Adverse Events in Cancer Genetic Testing:

More information

Corporate Medical Policy Genetic Testing for Breast and Ovarian Cancer

Corporate Medical Policy Genetic Testing for Breast and Ovarian Cancer Corporate Medical Policy Genetic Testing for Breast and Ovarian Cancer File Name: Origination: Last CAP Review: Next CAP Review: Last Review: genetic_testing_for_breast_and_ovarian_cancer 8/1997 8/2017

More information

Feasibility of Clinical Trial Implementation Genetically Eligible Prostate Cancer Patients Oliver Sartor, MD Cathryn E, Garvey, MS December 3, 2015

Feasibility of Clinical Trial Implementation Genetically Eligible Prostate Cancer Patients Oliver Sartor, MD Cathryn E, Garvey, MS December 3, 2015 Feasibility of Clinical Trial Implementation Genetically Eligible Prostate Cancer Patients Oliver Sartor, MD Cathryn E, Garvey, MS December 3, 2015 Study Name Feasibility of Patient Population for proposed

More information

6/8/17. Genetics 101. Professor, College of Medicine. President & Chief Medical Officer. Hereditary Breast and Ovarian Cancer 2017

6/8/17. Genetics 101. Professor, College of Medicine. President & Chief Medical Officer. Hereditary Breast and Ovarian Cancer 2017 Genetics 101 Hereditary Breast and Ovarian Cancer 2017 Rebecca Sutphen, MD, FACMG Professor, College of Medicine President & Chief Medical Officer INVASIVE CANCER GENETICALLY ALTERED CELL HYPERPLASIA DYSPLASIA

More information

Reference #: SYS-PC-VPCI-CG-002. Origination Date: June 2012 Next Review Date: April 2019 Effective Date: April 2016

Reference #: SYS-PC-VPCI-CG-002. Origination Date: June 2012 Next Review Date: April 2019 Effective Date: April 2016 Oncology Service Line-Allina Health System-wide Consensus Guidelines: Identification of Breast Cancer Patients at Risk for Inherited Cancer Risks These guidelines apply to clinical interventions that have

More information

GENETIC TESTING FOR HEREDITARY BREAST AND OVARIAN CANCER BRCA1 BRCA2

GENETIC TESTING FOR HEREDITARY BREAST AND OVARIAN CANCER BRCA1 BRCA2 GENETIC TESTING FOR HEREDITARY BREAST AND OVARIAN CANCER BRCA1 BRCA2 Coverage for services, procedures, medical devices and drugs are dependent upon benefit eligibility as outlined in the member's specific

More information

LESSON 3.2 WORKBOOK. How do normal cells become cancer cells? Workbook Lesson 3.2

LESSON 3.2 WORKBOOK. How do normal cells become cancer cells? Workbook Lesson 3.2 For a complete list of defined terms, see the Glossary. Transformation the process by which a cell acquires characteristics of a tumor cell. LESSON 3.2 WORKBOOK How do normal cells become cancer cells?

More information

HBOC. Jessica M. Salamone, ScM, CGC

HBOC. Jessica M. Salamone, ScM, CGC HBOC Jessica M. Salamone, ScM, CGC Certified Genetic Counselor Director of the Cancer Risk Assessment & Genetic Counseling Program Elizabeth Wende Breast Care, LLC Elizabeth Wende Breast Care Internationally

More information

Management of BRCA Positive Breast Cancer. Archana Ganaraj, MD February 17, 2018 UPDATE ON WOMEN S HEALTH

Management of BRCA Positive Breast Cancer. Archana Ganaraj, MD February 17, 2018 UPDATE ON WOMEN S HEALTH Management of BRCA Positive Breast Cancer Archana Ganaraj, MD February 17, 2018 UPDATE ON WOMEN S HEALTH The number of American women who have lost their lives to breast cancer outstrips the total number

More information

Genomic/Genetic Services: Barriers to Access. Sue Friedman, DVM National Academies of Science Roundtable 06/26/18

Genomic/Genetic Services: Barriers to Access. Sue Friedman, DVM National Academies of Science Roundtable 06/26/18 Genomic/Genetic Services: Barriers to Access Sue Friedman, DVM National Academies of Science Roundtable 06/26/18 No conflicts to disclose Disclosure Overview Awareness and knowledge Insurance coverage

More information

FEP Medical Policy Manual

FEP Medical Policy Manual FEP Medical Policy Manual Effective Date: October 15, 2018 Related Policies: 2.04.38 Cytochrome P450 Genotype-Guided Treatment Strategy Genotype-Guided Tamoxifen Treatment Description Tamoxifen is prescribed

More information

DNA is the genetic material that provides instructions for what our bodies look like and how they function. DNA is packaged into structures called

DNA is the genetic material that provides instructions for what our bodies look like and how they function. DNA is packaged into structures called DNA is the genetic material that provides instructions for what our bodies look like and how they function. DNA is packaged into structures called chromosomes. We have 23 pairs of chromosomes (for a total

More information

Genetics & Precision Medicine Cancer Care

Genetics & Precision Medicine Cancer Care Genetics & Precision Medicine Cancer Care Johnathan M. Lancaster, MD PhD Chief Medical Officer Myriad Genetics Copyright 2015 Myriad Genetics, Inc., all rights reserved. www.myriad.com. Precision Medicine

More information

Notes for slide 2 Welcome to today s training webinar. We appreciate everyone taking time today to hear our presentations. We are very excited to fina

Notes for slide 2 Welcome to today s training webinar. We appreciate everyone taking time today to hear our presentations. We are very excited to fina Notes for slide 2 Welcome to today s training webinar. We appreciate everyone taking time today to hear our presentations. We are very excited to finally be able to put these genomics related data items

More information

Cancer - the Beginning: Biology, Pathology and Genetic Predisposition

Cancer - the Beginning: Biology, Pathology and Genetic Predisposition Cancer - the Beginning: Biology, Pathology and Genetic Predisposition Disclosure I have no conflicts of interest in relation to this program or presentation. Ashley V Daley, MS, CGC Genetic Counselor Virginia

More information

The benefit of. knowing. Genetic testing for hereditary cancer. A patient support guide

The benefit of. knowing. Genetic testing for hereditary cancer. A patient support guide The benefit of knowing Genetic testing for hereditary cancer A patient support guide Does cancer run in your family? Cancer is more common in some families. Sometimes cancer is caused by a change in a

More information

Genetic Panel Testing and Implications for Cancer Care

Genetic Panel Testing and Implications for Cancer Care Genetic Panel Testing and Implications for Cancer Care Dana Zakalik, M.D. Nancy and James Grosfeld Cancer Genetics Center Professor, OUWB Medical School MCC Board of Directors Meeting September 28, 2016

More information

Precision Medicine and Genetic Counseling : Is Yes always the correct answer?

Precision Medicine and Genetic Counseling : Is Yes always the correct answer? Precision Medicine and Genetic Counseling : Is Yes always the correct answer? Beverly M. Yashar, MS, PhD, CGC Director, Graduate Program in Genetic Counseling Professor, Department of Human Genetics. (yashar@umich.edu)

More information

MEDICAL GENOMICS LABORATORY. Next-Gen Sequencing and Deletion/Duplication Analysis of NF1 Only (NF1-NG)

MEDICAL GENOMICS LABORATORY. Next-Gen Sequencing and Deletion/Duplication Analysis of NF1 Only (NF1-NG) Next-Gen Sequencing and Deletion/Duplication Analysis of NF1 Only (NF1-NG) Ordering Information Acceptable specimen types: Fresh blood sample (3-6 ml EDTA; no time limitations associated with receipt)

More information

Does Cancer Run in Your Family?

Does Cancer Run in Your Family? Does Cancer Run in Your Family? Nancie Petrucelli, MS, CGC Clinical Assistant Professor Certified Genetic Counselor/Coordinator Cancer Genetic Counseling Service Karmanos Cancer Institute Wayne State University

More information

Assessment and Management of Genetic Predisposition to Breast Cancer. Dr Munaza Ahmed Consultant Clinical Geneticist 2/7/18

Assessment and Management of Genetic Predisposition to Breast Cancer. Dr Munaza Ahmed Consultant Clinical Geneticist 2/7/18 Assessment and Management of Genetic Predisposition to Breast Cancer Dr Munaza Ahmed Consultant Clinical Geneticist 2/7/18 Overview The role of the Cancer Genetics team NICE guidelines for Familial Breast

More information

Genetics: More Than 23 and Me

Genetics: More Than 23 and Me Genetics: More Than 23 and Me Stephanie J. Offord, FNP-BC, AGN-BC, MSN Gina Lewis, CPNP-PC, MSN Suzanne Ducett, BSN, RN Interactive questions in presentation. Text NPGENETICS123 to 22333 once to join DISCLOSURE

More information

Genetics/Genomics: role of genes in diagnosis and/risk and in personalised medicine

Genetics/Genomics: role of genes in diagnosis and/risk and in personalised medicine Genetics/Genomics: role of genes in diagnosis and/risk and in personalised medicine Lynn Greenhalgh, Macmillan Cancer and General Clinical Geneticist Cancer Genetics Service Cancer is common 1 in

More information

Talking Genomes with Your Patients. Meagan Cochran, MS, CGC Certified Genetic Counselor HudsonAlpha Institute for Biotechnology

Talking Genomes with Your Patients. Meagan Cochran, MS, CGC Certified Genetic Counselor HudsonAlpha Institute for Biotechnology Talking Genomes with Your Patients Meagan Cochran, MS, CGC Certified Genetic Counselor HudsonAlpha Institute for Biotechnology Objectives Review the importance of physician familiarity with genomic testing

More information

Abstract # 1503: Predisposing germline mutations in high grade ER+ HER2- breast cancer patients diagnosed age < 50

Abstract # 1503: Predisposing germline mutations in high grade ER+ HER2- breast cancer patients diagnosed age < 50 Abstract # 1503: Predisposing germline mutations in high grade ER+ HER2- breast cancer patients diagnosed age < 50 Garber JE 1, Tung NM 2, Elkin EP 3, Allen BA 3, Singh NA 3, Wenstrup R 3, Hartman AR 3,

More information

Are you at risk of Hereditary Cancer? Your Guide to the Answers

Are you at risk of Hereditary Cancer? Your Guide to the Answers Are you at risk of Hereditary Cancer? Your Guide to the Answers What is Hereditary Cancer? The genes we are born with may contribute to our risk of developing certain types of cancer, including breast,

More information

Genetic testing for hereditary cancer

Genetic testing for hereditary cancer Genetic testing for hereditary cancer THE GENETICS OF HEREDITARY CANCER About half of all men and one-third of all women in the US will develop cancer during their lifetimes. Approximately 5% to 10% of

More information

Genetic Testing for Single-Gene and Multifactorial Conditions

Genetic Testing for Single-Gene and Multifactorial Conditions Clinical Appropriateness Guidelines Genetic Testing for Single-Gene and Multifactorial Conditions EFFECTIVE DECEMBER 1, 2017 Appropriate.Safe.Affordable 2017 AIM Specialty Health 2069-1217 Table of Contents

More information

WELCOME. Taking Care of Your Health. April 30, 8 am to noon

WELCOME. Taking Care of Your Health. April 30, 8 am to noon WELCOME Taking Care of Your Health April 30, 8 am to noon Cancer: Know Your Risk Emily Kuchinsky, MS, CGC, Certified Genetic Counselor Sporadic Cancer Lifetime Probability- Women Family Cluster Risk factors

More information

What is New in Genetic Testing. Steven D. Shapiro MS, DMD, MD

What is New in Genetic Testing. Steven D. Shapiro MS, DMD, MD What is New in Genetic Testing Steven D. Shapiro MS, DMD, MD 18th Annual Primary Care Symposium Financial and Commercial Disclosure I have a no financial or commercial interest in my presentation. 2 Genetic

More information

Disclosures. Clinical Practice Guidelines: The Role of the Genetic Counselor. I have no conflicts of interest to disclose.

Disclosures. Clinical Practice Guidelines: The Role of the Genetic Counselor. I have no conflicts of interest to disclose. Disclosures Clinical Practice Guidelines: The Role of the Genetic Counselor I have no conflicts of interest to disclose. Robert Pilarski, MS, LGC, MSW November 10, 2017 Objectives The participant will

More information

Why Pathway Genomics. Advanced Genetic Testing Laboratory. General Health and Wellness. Liquid Biopsy. Hereditary Cancer.

Why Pathway Genomics. Advanced Genetic Testing Laboratory. General Health and Wellness. Liquid Biopsy. Hereditary Cancer. Advanced Genetic Testing Laboratory General Health and Wellness Liquid Biopsy Hereditary Cancer Pharmacogenomics Carrier Screening Why Pathway Genomics Founded in 2008, Pathway Genomics offers digital

More information

GENETIC TESTING FOR HEREDITARY BREAST AND OVARIAN CANCER SYNDROME BRCA1 BRCA2

GENETIC TESTING FOR HEREDITARY BREAST AND OVARIAN CANCER SYNDROME BRCA1 BRCA2 SYNDROME BRCA1 BRCA2 Non-Discrimination Statement and Multi-Language Interpreter Services information are located at the end of this document. Coverage for services, procedures, medical devices and drugs

More information

Examine breast cancer trends, statistics, and death rates, and impact of screenings. Discuss benefits and risks of screening

Examine breast cancer trends, statistics, and death rates, and impact of screenings. Discuss benefits and risks of screening Define Breast Cancer Screening Examine breast cancer trends, statistics, and death rates, and impact of screenings Discuss benefits and risks of screening Compare and contrast Screening Guidelines Optimal

More information

"Genetic Testing and Genetic Counseling in Prostate Cancer"

Genetic Testing and Genetic Counseling in Prostate Cancer National Alliance of State Prostate Cancer Coalitions Webinar Series "Genetic Testing and Genetic Counseling in Prostate Cancer" Leonard G. Gomella, MD Chairman Department of Urology Sidney Kimmel Cancer

More information

GEN ETICS AN D GEN OM ICS IN CANCER PREVENTION AN D TREATM EN T. Robert Nathan Slotnick MD PhD Director, Medical Genetics and Genomics

GEN ETICS AN D GEN OM ICS IN CANCER PREVENTION AN D TREATM EN T. Robert Nathan Slotnick MD PhD Director, Medical Genetics and Genomics GEN ETICS AN D GEN OM ICS IN CANCER PREVENTION AN D TREATM EN T Robert Nathan Slotnick MD PhD Director, Medical Genetics and Genomics The Medical/Surgical/Radiation Oncologist s View of Genetics Cancer

More information

Objectives. Genetics in Cancer Treatment and Prevention. Genes

Objectives. Genetics in Cancer Treatment and Prevention. Genes Objectives Genetics in Cancer Treatment and Prevention Cheryl LaFlore, ARNP, MSN, BC Understand how to integrate genetic and genomic information into oncology nursing practice Define the role of an oncology

More information

Welcome! Here s our agenda for today:

Welcome! Here s our agenda for today: Welcome! Here s our agenda for today: What is ovarian cancer? What causes it? When does genetic testing come in? When are families at risk for ovarian cancer? What are the treatments? 3 things to remember

More information

Competent Pain Management for Older Patients With Cancer

Competent Pain Management for Older Patients With Cancer Session length: 2 hours, 53 minutes Contact hours: 3.5 Pharmacology hours offered: 30 minutes 2005 ONS Virtual Institutes of Learning Evaluation Form Competent Pain Management for Older Patients With Cancer

More information

BRCA 1/2. Breast cancer testing THINK ABOUT TOMORROW, TODAY

BRCA 1/2. Breast cancer testing THINK ABOUT TOMORROW, TODAY BRCA 1/2 Breast cancer testing THINK ABOUT TOMORROW, TODAY 5 10% of patients with breast and/or ovarian cancer have a hereditary form1. For any individual carrying a mutation in BRCA1 or BRCA2, the lifetime

More information

MEDICAL POLICY Genetic Testing for Breast and Ovarian Cancers

MEDICAL POLICY Genetic Testing for Breast and Ovarian Cancers POLICY: PG0067 ORIGINAL EFFECTIVE: 07/30/02 LAST REVIEW: 01/25/18 MEDICAL POLICY Genetic Testing for Breast and Ovarian Cancers GUIDELINES This policy does not certify benefits or authorization of benefits,

More information

Hereditary Breast and Ovarian Cancer Screening & Genetic Counseling

Hereditary Breast and Ovarian Cancer Screening & Genetic Counseling Hereditary Breast and Ovarian Cancer Screening & Genetic Counseling Cecelia Bellcross, PhD, MS, CGC Emory University School of Medicine Department of Human Genetics The First Line of Defense February 21,

More information

Carol Christianson, MS, CGC Genetic Counselor West Michigan Cancer Center

Carol Christianson, MS, CGC Genetic Counselor West Michigan Cancer Center Carol Christianson, MS, CGC Genetic Counselor West Michigan Cancer Center Following this presentation you will be able to: Identify cancer survivors in your practice who might benefit from genetic counseling

More information

Precision Medicine. Wendy Chung, MD PhD Director of Clinical Genetics Columbia University

Precision Medicine. Wendy Chung, MD PhD Director of Clinical Genetics Columbia University Precision Medicine Wendy Chung, MD PhD Director of Clinical Genetics Columbia University What is precision medicine? Providing the right treatment for the right patient at the right time and engaging the

More information

Germline Genetic Testing for Breast Cancer Risk

Germline Genetic Testing for Breast Cancer Risk Kathmandu, Bir Hospital visit, August 2018 Germline Genetic Testing for Breast Cancer Risk Evidence-based Genetic Screening Rodney J. Scott Demography in New South Wales (total population ~ 7,000,000)

More information

GYNplus: A Genetic Test for Hereditary Ovarian and/or Uterine Cancer

GYNplus: A Genetic Test for Hereditary Ovarian and/or Uterine Cancer GYNplus: A Genetic Test for Hereditary Ovarian and/or Uterine Cancer Causes of Hereditary Ovarian and Uterine Cancer uterine cancer ovarian cancer Sporadic 75-90% Sporadic 70-80% Hereditary, 5% Lynch syndrome

More information

Genetic counseling and testing. Shani Paluch-Shimon, MBBS, MSc Director, Breast Oncology Unit Shaare Zedek Medical Centre, Jerusalem Israel

Genetic counseling and testing. Shani Paluch-Shimon, MBBS, MSc Director, Breast Oncology Unit Shaare Zedek Medical Centre, Jerusalem Israel Genetic counseling and testing Shani Paluch-Shimon, MBBS, MSc Director, Breast Oncology Unit Shaare Zedek Medical Centre, Jerusalem Israel Disclosures Roche: Speakers bureau, honoraria, consultancy Astra

More information

Re: NC Medicaid and NC Health Choice Program coverage of genetic testing for susceptibility to breast and ovarian cancer

Re: NC Medicaid and NC Health Choice Program coverage of genetic testing for susceptibility to breast and ovarian cancer March 23, 2018 North Carolina (NC) Division of Medical Assistance (DMA), Clinical Policy Section C/O Pam Greeson, BSN, RN-C, pam.greeson@dhhs.nc.gov Nurse Consultant, Division of Medical Assistance Practitioners,

More information

Learn your genetic risk for the most common hereditary cancers.

Learn your genetic risk for the most common hereditary cancers. Learn your genetic risk for the most common hereditary cancers. color.com Color analyzes 30 genes including BRCA1 and BRCA2 to help women and men understand their risk for the most common hereditary cancers,

More information

The New World of Genomics

The New World of Genomics The New World of Genomics Amy Sturm, LCGC Associate Professor Department of Internal Medicine The Ohio State University Wexner Medical Center Learning Objectives To define genomic medicine To review early

More information

The New World of Genomics

The New World of Genomics The New World of Genomics Amy Sturm, LCGC Associate Professor Department of Internal Medicine The Ohio State University Wexner Medical Center Learning Objectives To define genomic medicine To review early

More information

GYNplus. genetic testing for hereditary ovarian and/or uterine cancer

GYNplus. genetic testing for hereditary ovarian and/or uterine cancer GYNplus genetic testing for hereditary ovarian and/or uterine cancer What Are the Causes of Hereditary Ovarian and Uterine Cancer? uterine cancer ovarian cancer sporadic 70-80% hereditary 5% Lynch syndrome

More information

Cancer Survivorship Symposium Cancer and Heredity January 16, Jeanne P. Homer, MS Licensed Certified Genetic Counselor

Cancer Survivorship Symposium Cancer and Heredity January 16, Jeanne P. Homer, MS Licensed Certified Genetic Counselor Cancer Survivorship Symposium Cancer and Heredity January 16, 2017 Jeanne P. Homer, MS Licensed Certified Genetic Counselor Outline Cancer and Heredity Hereditary Cancer Risk Assessment & Genetic testing

More information

Identification of patients suggestive of hereditary breast and ovarian cancer syndrome that warrants further professional evaluation.

Identification of patients suggestive of hereditary breast and ovarian cancer syndrome that warrants further professional evaluation. Allina Breast Program Committee Consensus Guidelines These guidelines apply to clinical interventions that have well-documented outcomes, but whose outcomes are not clearly desirable to all patients Identification

More information

Incorporating Hereditary Cancer Risk Assessment into Your Practice

Incorporating Hereditary Cancer Risk Assessment into Your Practice Incorporating Hereditary Cancer Risk Assessment into Your Practice DISCLAIMER This information is provided to help answer questions with respect to hereditary cancer risk assessment and hereditary cancer

More information

CASE STUDY. Germline Test for Mother and Follow up Testing for Daughter: Assessment of Hereditary Cancer Risk. Introduction.

CASE STUDY. Germline Test for Mother and Follow up Testing for Daughter: Assessment of Hereditary Cancer Risk. Introduction. CASE STUDY Germline Test for Mother and Follow up Testing for Daughter: Assessment of Hereditary Cancer Risk Introduction Germline cancer risk assessment tests are well-prescribed tests from Strand Life

More information

Freedom. Bring the American Lung Association s premier smoking cessation solution to your workplace. FROM SMOKING

Freedom. Bring the American Lung Association s premier smoking cessation solution to your workplace. FROM SMOKING Freedom FROM SMOKING Bring the American Lung Association s premier smoking cessation solution to your workplace. Choose the option that s best for your organization. Freedom FROM SMOKING Freedom From Smoking

More information

Hands-On Ten The BRCA1 Gene and Protein

Hands-On Ten The BRCA1 Gene and Protein Hands-On Ten The BRCA1 Gene and Protein Objective: To review transcription, translation, reading frames, mutations, and reading files from GenBank, and to review some of the bioinformatics tools, such

More information

PROVIDER POLICIES & PROCEDURES

PROVIDER POLICIES & PROCEDURES PROVIDER POLICIES & PROCEDURES BRCA GENETIC TESTING The purpose of this document is to assist providers enrolled in the Connecticut Medical Assistance Program (CMAP) with the information needed to support

More information

MEDICAL GENOMICS LABORATORY. Peripheral Nerve Sheath Tumor Panel by Next-Gen Sequencing (PNT-NG)

MEDICAL GENOMICS LABORATORY. Peripheral Nerve Sheath Tumor Panel by Next-Gen Sequencing (PNT-NG) Peripheral Nerve Sheath Tumor Panel by Next-Gen Sequencing (PNT-NG) Ordering Information Acceptable specimen types: Blood (3-6ml EDTA; no time limitations associated with receipt) Saliva (OGR-575 DNA Genotek;

More information

Outline. Identifying your risk for hereditary breast or ovarian cancer. Genetics 101. What causes cancer? Genetics

Outline. Identifying your risk for hereditary breast or ovarian cancer. Genetics 101. What causes cancer? Genetics Identifying your risk for hereditary breast or ovarian cancer David Andorsky, MD Breanna Roscow, MS, CGC 303-993-0161 Outline Genetics and biology of hereditary cancer syndromes BRCA1 and BRCA2 Genetic

More information

COLON CANCER & GENETICS VERMONT COLORECTAL CANCER SUMMIT NOVEMBER 15, 2014

COLON CANCER & GENETICS VERMONT COLORECTAL CANCER SUMMIT NOVEMBER 15, 2014 COLON CANCER & GENETICS VERMONT COLORECTAL CANCER SUMMIT NOVEMBER 15, 2014 WENDY MCKINNON, MS, CGC CERTIFIED GENETIC COUNSELOR FAMILIAL CANCER PROGRAM UNIVERSIT Y OF VERMONT MEDICAL CENTER 1 CHARACTERISTICS

More information

CASE STUDY. Germline Cancer Testing in A Proband: Extension of Benefits to Unaffected Family Members. Introduction. Patient Profile.

CASE STUDY. Germline Cancer Testing in A Proband: Extension of Benefits to Unaffected Family Members. Introduction. Patient Profile. CASE STUDY Germline Cancer Testing in A Proband: Extension of Benefits to Unaffected Family Members Introduction Most cancers are caused by genetic damage resulting from random mutations and exposure to

More information

AllinaHealthSystems 1

AllinaHealthSystems 1 Overview Biology and Introduction to the Genetics of Cancer Denise Jones, MS, CGC Certified Genetic Counselor Virginia Piper Cancer Service Line I. Our understanding of cancer the historical perspective

More information

Breast Cancer: Who Gets It? Who Survives? The Latest Information

Breast Cancer: Who Gets It? Who Survives? The Latest Information Breast Cancer: Who Gets It? Who Survives? The Latest Information James J. Stark, MD, FACP Medical Director, Cancer Program and Director of Palliative Care Maryview Medical Center Professor of Medicine

More information

NCCN Guidelines for Prostate V Meeting on 06/28/18

NCCN Guidelines for Prostate V Meeting on 06/28/18 Guideline Page and Request PROS-2 through PROS-11 and PROS-D (pages 3 and 4). External request from GenomeDx Biosciences Request the NCCN Prostate Cancer Guidelines Panel to review the data in support

More information

Page 1 of 5 Home > Research & Grants > Research and Scientific Programs > What is genetic testing for breast cancer and who should get it? What is genetic testing for breast cancer and who should get it?

More information

Developing Better Medicine

Developing Better Medicine SURF 2013 Marietta L. Harrison, PhD Director, Oncological Sciences Center in Discovery Park Professor, Medicinal Chemistry and Molecular Pharmacology How we do it today One size fits all Medicines aren

More information

Genomics Up Close And Personal: What Are The Implications For Cancer Nursing? Candy Cooley Head of Education

Genomics Up Close And Personal: What Are The Implications For Cancer Nursing? Candy Cooley Head of Education Genomics Up Close And Personal: What Are The Implications For Cancer Nursing? Candy Cooley Head of Education Aims of this session Understand how genomic information will change your clinical practice Remind

More information

Universal Screening for Lynch Syndrome

Universal Screening for Lynch Syndrome Universal Screening for Lynch Syndrome St. Vincent/Ameripath protocol proposal Lynch syndrome (HNPCC) 1/35 individuals with colorectal cancer has Lynch syndrome Over half individuals are >50 at time of

More information

Evaluation & Management of PowerPoint Cover Title. the High Risk Population. High Risk Clinic

Evaluation & Management of PowerPoint Cover Title. the High Risk Population. High Risk Clinic Evaluation & Management of PowerPoint Cover Title the High Risk Population High Risk Clinic Subtitle Joanna Would Springman, Go Here PA-C Assessment Genetics Known genetic mutation Family history with

More information

Genetic Testing for BRCA1 and BRCA2 Genes

Genetic Testing for BRCA1 and BRCA2 Genes Genetic Testing for BRCA1 and BRCA2 Genes MP9478 Covered Service: Prior Authorization Required: Additional Information: Yes when meets criteria below Yes as shown below Pre and post-test genetic counseling

More information

Genetics and Cancer Care. Cynthia Forster-Gibson, MD, PhD and Loren Mackay- Loder, MSc Genetics Program, THP

Genetics and Cancer Care. Cynthia Forster-Gibson, MD, PhD and Loren Mackay- Loder, MSc Genetics Program, THP Genetics and Cancer Care Cynthia Forster-Gibson, MD, PhD and Loren Mackay- Loder, MSc Genetics Program, THP Faculty/Presenter Disclosure Faculty: Cynthia Forster-Gibson Relationships with commercial interests:

More information

Information for You and Your Family

Information for You and Your Family Information for You and Your Family What is Prevention? Cancer prevention is action taken to lower the chance of getting cancer. In 2017, more than 1.6 million people will be diagnosed with cancer in the

More information

Guidelines and Clinical Utility of Molecular Diagnostics

Guidelines and Clinical Utility of Molecular Diagnostics Guidelines and Clinical Utility of Molecular Diagnostics Al B. Benson III, MD, FACP Professor of Medicine Associate Director for Clinical Investigations Robert H. Lurie Comprehensive Cancer Center of Northwestern

More information

The Role of Genetics in Ovarian Cancer Screening. Dawn DeLozier, Ph.D. Medical Geneticist, SAMC Associate Professor UCSF-Fresno

The Role of Genetics in Ovarian Cancer Screening. Dawn DeLozier, Ph.D. Medical Geneticist, SAMC Associate Professor UCSF-Fresno The Role of Genetics in Ovarian Cancer Screening Dawn DeLozier, Ph.D. Medical Geneticist, SAMC Associate Professor UCSF-Fresno How Much Breast and Ovarian Cancer Is Hereditary? 15%-20% 5%-10% Breast Cancer

More information